Rapt Therapeutics Long Term Deferred Charges (Quarterly) Insights

Rapt Therapeutics, Inc. (RAPT)

33.02 +1.82 (+5.82%) USD | NASDAQ | Jan 09, 15:44

View Long Term Deferred Charges (Quarterly) for RAPT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Replimune Group, Inc.	--
Olema Pharmaceuticals, Inc.	--
NovaBay Pharmaceuticals, Inc.	--
Palatin Technologies, Inc.	--
Theriva Biologics, Inc.	--